Ghadiminezhad Daru

Ghadiminezhad Daru is an Iranian pharmaceutical company based in Tehran, founded by Iraj Ghadiminejad. The company is the manufacturer and sponsor of ENDOR, a natural anti-inflammatory oral combination drug and topical product line originally developed by GNP Australia. ENDOR is formulated with natural precursors (including Curcuma longa extract, fish oil, zinc sulfate, and vitamins) that allow the body to naturally down-regulate overactive immune responses. Ghadiminezhad Daru has manufactured these products for clinical trials, including a randomized controlled trial evaluating ENDOR's efficacy in hospitalized COVID-19 patients, as well as for the treatment of autoimmune and inflammatory skin conditions such as psoriasis, eczema, and rosacea.